Market Tracker

06/22 5:16pm ET

Novo Nordisk A/S (NYSE:NVO)

43.67
Delayed Data
As of 4:02pm ET
 -0.04 / -0.09%
Today’s Change
30.89
Today|||52-Week Range
57.41
+21.78%
Year-to-Date

Today’s Trading

Previous close43.71
Today’s open43.57
Day’s range43.50 - 43.93
Volume1,901,649
Average volume (3 months)2,317,753
Market cap$83.8B
Dividend yield3.07%
Data as of 4:02pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.75%
Revenue growth (last year)+3.81%
P/E ratio2.9
Price/Sales5.48
Price/Book17.05

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.70+1.44%
AGNAllergan+2.72+1.11%
AZNAstraZeneca+0.48+1.38%
LLYEli Lilly and Co+1.67+2.02%
Data as of 4:02pm ET, 06/22/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.56
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts